Towards spatial frequency domain optical imaging of neurovascular coupling in a mouse model of Alzheimer's disease

Early neurovascular coupling (NVC) changes in Alzheimer's disease can potentially provide imaging biomarkers to assist with diagnosis and treatment. Previous efforts to quantify NVC with intrinsic signal imaging have required assumptions of baseline optical pathlength to calculate changes in oxy- and deoxy-hemoglobin concentrations during evoked stimuli. In this work, we present an economical spatial frequency domain imaging (SFDI) platform utilizing a commercially available LED projector, camera, and off-the-shelf optical components suitable for imaging dynamic optical properties. The fast acquisition platform described in this work is validated on silicone phantoms and demonstrated in neuroimaging of a mouse model.

[1]  Gian Luigi Lenzi,et al.  Cerebrovascular Reactivity in Degenerative and Vascular Dementia: A Transcranial Doppler Study , 2007, European Neurology.

[2]  David Hsiang,et al.  Effects of motion on optical properties in the spatial frequency domain. , 2011, Journal of biomedical optics.

[3]  Fabrizio Vernieri,et al.  Cerebrovascular Reactivity and Cognitive Decline in Patients With Alzheimer Disease , 2006, Stroke.

[4]  Anthony J. Durkin,et al.  Modulated imaging: quantitative analysis and tomography of turbid media in the spatial-frequency domain. , 2005, Optics letters.

[5]  Anthony J. Durkin,et al.  Quantitation and mapping of tissue optical properties using modulated imaging. , 2009, Journal of biomedical optics.

[6]  E. Rüther,et al.  Cerebrovascular reactivity to acetazolamide in (senile) dementia of Alzheimer's type: relationship to disease severity. , 1995, Dementia.

[7]  Anthony J. Durkin,et al.  Multispectral imaging of tissue absorption and scattering using spatial frequency domain imaging and a computed-tomography imaging spectrometer. , 2011, Journal of biomedical optics.

[8]  Ann-Christine Ehlis,et al.  Altered parietal brain oxygenation in Alzheimer's disease as assessed with near-infrared spectroscopy. , 2010, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[9]  F. LaFerla,et al.  Alzheimer's disease. , 2010, The New England journal of medicine.

[10]  Phillip B. Jones,et al.  Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. , 2007, Brain : a journal of neurology.

[11]  Sylvain Gioux,et al.  Wavelength optimization for rapid chromophore mapping using spatial frequency domain imaging. , 2010, Journal of biomedical optics.

[12]  W. Klunk,et al.  Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound‐B , 2004, Annals of neurology.

[13]  T. Sera,et al.  rCBF SPECT and the acetazolamide test in the evaluation of dementia. , 1998, Nuclear medicine review. Central & Eastern Europe.

[14]  Ann-Christine Ehlis,et al.  Reduced prefrontal oxygenation in Alzheimer disease during verbal fluency tasks. , 2008, The American journal of geriatric psychiatry : official journal of the American Association for Geriatric Psychiatry.

[15]  Bruce J. Tromberg,et al.  Spatial Frequency Domain Imaging of Intrinsic Optical Property Contrast in a Mouse Model of Alzheimer’s Disease , 2011, Annals of Biomedical Engineering.

[16]  Charles D. Smith,et al.  Neuropathology of nondemented aging: Presumptive evidence for preclinical Alzheimer disease , 2009, Neurobiology of Aging.

[17]  David J Mikulis,et al.  Blood‐oxygen level dependent MRI measures of cerebrovascular reactivity using a controlled respiratory challenge: Reproducibility and gender differences , 2010, Journal of magnetic resonance imaging : JMRI.

[18]  Marina Diomedi,et al.  CSF biomarkers, impairment of cerebral hemodynamics and degree of cognitive decline in Alzheimer's and mixed dementia , 2009, Journal of the Neurological Sciences.

[19]  Jinsoo Uh,et al.  Forebrain-dominant deficit in cerebrovascular reactivity in Alzheimer's disease , 2012, Neurobiology of Aging.